Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 706 AL 720

Comparisons of neurodegeneration over time between healthy ageing and Alzheimer's disease cohorts via Bayesian inference

Cespedes MI, Fripp J, McGree JM, Drovandi CC, Mengersen K, Doecke JD.

BMJ Open. 2017 Feb 7;7(2):e012174. doi: 10.1136/bmjopen-2016-012174.

Cognitive Correlates of Timed Up and Go Subtasks in Older People With Preserved Cognition, Mild Cognitive Impairment, and Alzheimer's Disease

Ansai JH, Andrade LP, Nakagawa TH, Vale FAC, Caetano MJD, Lord SR, Rebelatto JR.

Am J Phys Med Rehabil. 2017 Oct;96(10):700-705. doi: 10.1097/PHM.0000000000000722.

Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease

Malojcic B, Giannakopoulos P, Sorond FA, Azevedo E, Diomedi M, Oblak JP, Carraro N, Boban M, Olah L, Schreiber SJ, Pavlovic A, Garami Z, Bornstein NM, Rosengarten B.

BMC Med. 2017 Feb 9;15(1):27. doi: 10.1186/s12916-017-0799-3.

Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers

Miki T, Shimada H, Kim JS, Yamamoto Y, Sugino M, Kowa H, Heurling K, Zanette M, Sherwin PF, Senda M.

Ann Nucl Med. 2017 Apr;31(3):260-272. doi: 10.1007/s12149-017-1154-7. Epub 2017 Feb 8.

Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?

Piirainen S, Youssef A, Song C, Kalueff AV, Landreth GE, Malm T, Tian L.

Neurosci Biobehav Rev. 2017 Jun;77:148-164. doi: 10.1016/j.neubiorev.2017.01.046. Epub 2017 Feb 6.

[Alzheimer's disease and epilepsy]

Haussmann R, Mayer T, Schrempf W, Donix M.

Nervenarzt. 2017 Sep;88(9):1003-1009. doi: 10.1007/s00115-017-0286-2.

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease

Geifman N, Brinton RD, Kennedy RE, Schneider LS, Butte AJ.

Alzheimers Res Ther. 2017 Feb 17;9(1):10. doi: 10.1186/s13195-017-0237-y.

The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism

Nixon DW.

Curr Alzheimer Res. 2017;14(8):883-893. doi: 10.2174/1567205014666170216152905.

Genetic Stratification to Identify Risk Groups for Alzheimer's Disease

Marioni RE, Campbell A, Hagenaars SP, Nagy R, Amador C, Hayward C, Porteous DJ, Visscher PM, Deary IJ.

J Alzheimers Dis. 2017;57(1):275-283. doi: 10.3233/JAD-161070.

DTI measurements for Alzheimer's classification

Maggipinto T, Bellotti R, Amoroso N, Diacono D, Donvito G, Lella E, Monaco A, Antonella Scelsi M, Tangaro S.

Phys Med Biol. 2017 Mar 21;62(6):2361-2375. doi: 10.1088/1361-6560/aa5dbe. Epub 2017 Feb 24.

Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease

Jia J, Gauthier S, Pallotta S, Ji Y, Wei W, Xiao S, Peng D, Guo Q, Wu L, Chen S, Kuang W, Zhang J, Wei C, Tang Y.

Alzheimers Dement. 2017 May;13(5):592-597. doi: 10.1016/j.jalz.2017.01.007. Epub 2017 Feb 24.

Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins

Huynh TV, Davis AA, Ulrich JD, Holtzman DM.

J Lipid Res. 2017 May;58(5):824-836. doi: 10.1194/jlr.R075481. Epub 2017 Feb 27.

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Fujino T, Yamada T, Asada T, Tsuboi Y, Wakana C, Mawatari S, Kono S.

EBioMedicine. 2017 Mar;17:199-205. doi: 10.1016/j.ebiom.2017.02.012. Epub 2017 Feb 24.

Fractional anisotropy derived from the diffusion tensor distribution function boosts power to detect Alzheimer's disease deficits

Nir TM, Jahanshad N, Villalon-Reina JE, Isaev D, Zavaliangos-Petropulu A, Zhan L, Leow AD, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Diseaase Neuroimaginng Initiative (ADNI).

Magn Reson Med. 2017 Dec;78(6):2322-2333. doi: 10.1002/mrm.26623. Epub 2017 Mar 7.

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients

Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM.

J Alzheimers Dis. 2017;57(2):557-573. doi: 10.3233/JAD-160216.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias